Get started
Author

Carlo Stresemann

Observed names: C Stresemann, Stresemann, Carlo
Institution: Nuvisan (Germany)
ORCID: 0000-0002-1147-0927
Observed ORCID: 0000-0002-1147-0927
OpenAlex ID: A5007802195
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
2008 · Carlo Stresemann, Frank Lyko · International Journal of Cancer · 974
The Human let-7a-3 Locus Contains an Epigenetically Regulated MicroRNA Gene with Oncogenic Function
2007 · Bodo Brueckner, Carlo Stresemann, et al. · Cancer Research · 452
PDF
Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines
2006 · Carlo Stresemann, Bodo Brueckner, et al. · Cancer Research · 395
Methylation of Human MicroRNA Genes in Normal and Neoplastic Cells
2007 · Barbara Weber, Carlo Stresemann, et al. · Cell Cycle · 281
PDF
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
2022 · Hamed Alborzinia, Andrés F. Flórez, et al. · Nature Cancer · 217
PDF
Characterization of DNA Demethylation Effects Induced by 5-Aza-2′-Deoxycytidine in Patients with Myelodysplastic Syndrome
2005 · Cora Mund, Björn Hackanson, et al. · Cancer Research · 112
PDF
Azacytidine causes complex DNA methylation responses in myeloid leukemia
2008 · Carlo Stresemann, Imke Bokelmann, et al. · Molecular Cancer Therapeutics · 101
Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
2016 · Nicolas Reynoird, Pawel K. Mazur, et al. · Genes & Development · 94
PDF
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
2016 · Erik Eggert, Roman C. Hillig, et al. · Journal of Medicinal Chemistry · 93
PDF
Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation
2009 · Maria Rius, Carlo Stresemann, et al. · Molecular Cancer Therapeutics · 73
EZH2 Inhibition Blocks Multiple Myeloma Cell Growth through Upregulation of Epithelial Tumor Suppressor Genes
2015 · Henar Hernando, Kathy A. Gelato, et al. · Molecular Cancer Therapeutics · 62
Identification of Small Molecules that Modulate Mutant p53 Condensation
2020 · Clara Lemos, Luise Schulze, et al. · iScience · 56
PDF
Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target
2020 · Krzysztof Brzezinka, Ekaterina Nevedomskaya, et al. · Cancers · 46
PDF
MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
2010 · on behalf of DeCOG, J C Hassel, et al. · British Journal of Cancer · 45
PDF
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
2019 · Krzysztof Brzezinka, Ekaterina Nevedomskaya, et al. · Journal of Hematology & Oncology · 33
PDF
Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening
2021 · Stefan Gradl, Holger Steuber, et al. · SLAS DISCOVERY · 31
PDF
Quantification of Histone H3 Lys27 Trimethylation (H3K27me3) by High-Throughput Microscopy Enables Cellular Large-Scale Screening for Small-Molecule EZH2 Inhibitors
2014 · Svenja Luense, Philip Denner, et al. · SLAS DISCOVERY · 25
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling
2024 · Keith Graham, Philip Lienau, et al. · Cell chemical biology · 16
Antiproliferative Effects of DNA Methyltransferase 3B Depletion Are Not Associated with DNA Demethylation
2012 · Sabine Hagemann, Dirk Kuck, et al. · PLoS ONE · 15
PDF
A miniaturized mode-of-action profiling platform enables high throughput characterization of the molecular and cellular dynamics of EZH2 inhibition
2024 · Lilia Falkenstern, Victoria Georgi, et al. · Scientific Reports · 8
PDF
Abstract 1646: Discovery and characterization of BAY-6035, a novel benzodiazepine-based SMYD3 inhibitor
2018 · Stefan Gradl, Holger Steuber, et al. · Cancer Research · 3
Abstract 2829: Discovery and in vitro and in vivo characterization of aminopyrazoline-based SMYD2 inhibitors
2015 · Carlo Stresemann, Ingo Hartung, et al. · Cancer Research · 1
Abstract 31: Characterization and cross comparison of cancer xenografts in humanized mice
2025 · Ulrike Litzenburger, Stephanie Stahnke, et al. · Cancer Research
Abstract 4584: Novel YAP1/TAZ pathway inhibitors identified through phenotypic screening with potent anti-tumor activity via blockade of GGTase-I and Rho-GTPase signaling
2024 · Keith Graham, Philip Lienau, et al. · Cancer Research
Abstract C079: Comprehensive immunophenotypic profiling sheds light on the dynamic interplay between immune cells in the 4T1 breast cancer model upon anti-PD1 and anti-CTLA4 immunotherapy
2023 · Christos Nikolaou, Simon Heller, et al. · Molecular Cancer Therapeutics
Works count: 57
Citation count: 3,133
H-index: 17
I10-index: 19
Year
Topic
Type